Age Related Changes in Calciotropic Hormones and Their Impact on Male Osteoporosis
Pilot Study to Assess the Skeletal Effects of Age-related Changes in Calcium and Vitamin D Metabolism in Men
2 other identifiers
observational
24
1 country
1
Brief Summary
The purpose of this pilot study is to generate preliminary data regarding the skeletal effects of age-related changes in calcium and vitamin D metabolism in older men.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2000
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2000
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2002
CompletedFirst Submitted
Initial submission to the registry
December 27, 2007
CompletedFirst Posted
Study publicly available on registry
January 9, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedAugust 30, 2023
August 1, 2023
1.7 years
December 27, 2007
August 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bone density of hip and spine
measured after screening evaluation
Secondary Outcomes (1)
calciotropic hormones, including calcium, PTH and vitamin D metabolites
measured after screening evaluation
Study Arms (1)
1
men 50 yrs of age or older
Eligibility Criteria
Healthy men 50 yrs of age and older, without a known history of metabolic bone disease or renal insufficiency
You may qualify if:
- healthy men age 50 yrs and older
You may not qualify if:
- smokers
- known history of metabolic bone disease, known history of hypogonadism or renal insufficiency.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
- National Institute on Aging (NIA)collaborator
Study Sites (1)
Yale Center for Clinical Investigation
New Haven, Connecticut, 06520, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barbara I Gulanski, MD, MPH
Yale University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 27, 2007
First Posted
January 9, 2008
Study Start
October 1, 2000
Primary Completion
July 1, 2002
Study Completion
December 1, 2008
Last Updated
August 30, 2023
Record last verified: 2023-08